Investment Strategy
Venture Capital
Vivo Innovation Fund focuses on investing in venture stage companies with the potential to develop game changing healthcare technologies or products.
Private Equity
Vivo Capital’s private equity strategy is focused particularly on underwriting the operational and commercial scale-up of companies with attractive growth prospects. Vivo’s growth capital strategy focuses on providing capital to companies at critical stages in their lifecycle to catalyze or accelerate commercial growth, whereas the buyout strategy will focus on situations (e.g., leveraged buyouts, management buyouts, spin-offs, restructurings, etc.) where a controlling stake can be acquired.
Public Equity
Vivo Opportunity Fund primarily invests in the global public equities of small and mid-cap biotechnology, pharmaceutical, healthcare and life science companies. The fund is long-only and often invests directly into companies through various financing structures, including follow-ons, PIPEs, registered directs, and IPOs.